Literature DB >> 21402817

Medical response to a nuclear detonation: creating a playbook for state and local planners and responders.

Paula Murrain-Hill1, C Norman Coleman, John L Hick, Irwin Redlener, David M Weinstock, John F Koerner, Delaine Black, Melissa Sanders, Judith L Bader, Joseph Forsha, Ann R Knebel.   

Abstract

For efficient and effective medical responses to mass casualty events, detailed advanced planning is required. For federal responders, this is an ongoing responsibility. The US Department of Health and Human Services (DHHS) prepares playbooks with formal, written plans that are reviewed, updated, and exercised regularly. Recognizing that state and local responders with fewer resources may be helped in creating their own event-specific response plans, subject matter experts from the range of sectors comprising the Scarce Resources for a Nuclear Detonation Project, provided for this first time a state and local planner's playbook template for responding to a nuclear detonation. The playbook elements are adapted from DHHS playbooks with appropriate modification for state and local planners. Individualization by venue is expected, reflecting specific assets, populations, geography, preferences, and expertise. This playbook template is designed to be a practical tool with sufficient background information and options for step-by-step individualized planning and response.

Entities:  

Mesh:

Year:  2011        PMID: 21402817     DOI: 10.1001/dmp.2011.13

Source DB:  PubMed          Journal:  Disaster Med Public Health Prep        ISSN: 1935-7893            Impact factor:   1.385


  9 in total

1.  Chemical, Biological, Radiological, Nuclear, and Explosive (CBRNE) Science and the CBRNE Science Medical Operations Science Support Expert (CMOSSE).

Authors:  C Norman Coleman; Judith L Bader; John F Koerner; Chad Hrdina; Kenneth D Cliffer; John L Hick; James J James; Monique K Mansoura; Alicia A Livinski; Scott V Nystrom; Andrea DiCarlo-Cohen; Maria Julia Marinissen; Lynne Wathen; Jessica M Appler; Brooke Buddemeier; Rocco Casagrande; Derek Estes; Patrick Byrne; Edward M Kennedy; Ann A Jakubowski; Cullen Case; David M Weinstock; Nicholas Dainiak; Dan Hanfling; Andrew L Garrett; Natalie N Grant; Daniel Dodgen; Irwin Redlener; Thomas F MacKAY; Meghan Treber; Mary J Homer; Tammy P Taylor; Aubrey Miller; George Korch; Richard Hatchett
Journal:  Disaster Med Public Health Prep       Date:  2019-12       Impact factor: 1.385

2.  Bactericidal/permeability-increasing protein (rBPI21) and fluoroquinolone mitigate radiation-induced bone marrow aplasia and death.

Authors:  Eva C Guinan; Christine M Barbon; Leslie A Kalish; Kalindi Parmar; Jeff Kutok; Christy J Mancuso; Liat Stoler-Barak; Eugénie E Suter; Janice D Russell; Christine D Palmer; Leighanne C Gallington; Annie Voskertchian; Jo-Anne Vergilio; Geoffrey Cole; Kaya Zhu; Alan D'Andrea; Robert Soiffer; Jerrold P Weiss; Ofer Levy
Journal:  Sci Transl Med       Date:  2011-11-23       Impact factor: 17.956

3.  Public health and medical preparedness for a nuclear detonation: the nuclear incident medical enterprise.

Authors:  C Norman Coleman; Julie M Sullivan; Judith L Bader; Paula Murrain-Hill; John F Koerner; Andrew L Garrett; David M Weinstock; Cullen Case; Chad Hrdina; Steven A Adams; Robert C Whitcomb; Ellie Graeden; Robert Shankman; Timothy Lant; Bert W Maidment; Richard C Hatchett
Journal:  Health Phys       Date:  2015-02       Impact factor: 1.316

Review 4.  Radiation injury after a nuclear detonation: medical consequences and the need for scarce resources allocation.

Authors:  Andrea L DiCarlo; Carmen Maher; John L Hick; Dan Hanfling; Nicholas Dainiak; Nelson Chao; Judith L Bader; C Norman Coleman; David M Weinstock
Journal:  Disaster Med Public Health Prep       Date:  2011-03       Impact factor: 1.385

Review 5.  Mitigating the risk of radiation-induced cancers: limitations and paradigms in drug development.

Authors:  Stephen S Yoo; Timothy J Jorgensen; Ann R Kennedy; John D Boice; Alla Shapiro; Tom C-C Hu; Brian R Moyer; Marcy B Grace; Gary J Kelloff; Michael Fenech; Pataje G S Prasanna; C Norman Coleman
Journal:  J Radiol Prot       Date:  2014-04-14       Impact factor: 1.394

6.  Gene Expression in Parp1 Deficient Mice Exposed to a Median Lethal Dose of Gamma Rays.

Authors:  M A Suresh Kumar; Evagelia C Laiakis; Shanaz A Ghandhi; Shad R Morton; Albert J Fornace; Sally A Amundson
Journal:  Radiat Res       Date:  2018-05-10       Impact factor: 2.841

7.  Biodosimetry: Medicine, Science, and Systems to Support the Medical Decision-Maker Following a Large Scale Nuclear or Radiation Incident.

Authors:  C Norman Coleman; John F Koerner
Journal:  Radiat Prot Dosimetry       Date:  2016-07-29       Impact factor: 0.954

8.  Preparedness for a 'no-notice' mass-casualty incident: a nuclear detonation scenario.

Authors:  C Norman Coleman; Kenneth D Cliffer; Andrea L DiCarlo; Mary J Homer; Brian R Moyer; Shannon G Loelius; Adam W Tewell; Judith L Bader; John F Koerner
Journal:  Int J Radiat Biol       Date:  2021-12-13       Impact factor: 3.352

9.  A translatable predictor of human radiation exposure.

Authors:  Joseph Lucas; Holly K Dressman; Sunil Suchindran; Mai Nakamura; Nelson J Chao; Heather Himburg; Kerry Minor; Gary Phillips; Joel Ross; Majid Abedi; Robert Terbrueggen; John P Chute
Journal:  PLoS One       Date:  2014-09-25       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.